Technical evaluation of an immunological method
Detailed description
THE COMPANY
Global dialysis player
THE TASK
3R LifeScience was asked technically to assess a novel immunological method and its applicability.
OUR SOLUTION
We conducted interviews with the partnering company, analyzed the technical documentation, markets and existing products and evaluated integration options, thereby providing an independent assessment of the feasibility and chances of project success.
The project risk analysis led to a prioritization of targets and operational milestones for implementation.
CLIENT BENEFIT
The client gained a comprehensive understanding of the technology status, the IP situation and project risks associated with the novel immunological method. This helped the client to decide and prioritize the development project.
“We understand that the new medical device regulations affect many organisations and raise many questions.”
Together with one of our experts, you clarify your requirements and questions. If cooperation appears helpful, we will arrange a workshop with you.
If you already have clarity about your project requirements and now need support as soon as possible, do not hesitate to call us.